For reasons discussed in more detail under General Clinical Trial Issues, below, all three trials heavily weight the estimate of pooled effect toward a null value.
Thus, all RTs analyzed below were from trials on which both the search and memory responses were correct.
We summarize the results of these trials below, focusing on patient populations who may benefit from PAC use where possible.
There are significant difficulties in conducting clinical VitD research, which are elaborated below, but these trials can be individually critiqued.
The Laboratory Biosphere experiment's light efficiency was somewhat higher than the USU field results but somewhat below greenhouse trials at comparable light levels, and the best portion of the crop at 0.22 g mol−1 was in-between those values.
Since hyperactive inflammation is one well-recognized feature of ALI/ARDS [ 5, 6] (see below), several trials of steroid effectiveness in patients with ALI/ARDS have been conducted.
The relevant section of our article with corrected text follows below: Seven trials were designed to detect the presence of endoscopic ulcers of 3 mm or more, in which celecoxib was compared with placebo and/or NSAID (additional file 4).
